Global Blood Therapeutics Receives a Buy from Wedbush

Wedbush analyst Liana Moussatos reiterated a Buy rating on Global Blood Therapeutics (NASDAQ: GBT) today and set a price target of $70. The company’s shares opened today at $40.60. According to, More »

Monday’s Midday Movers: Arrowhead Research (ARWR), Invivo Therapeutics Holdings (NVIV), IsoRay (ISR), Biocept Inc (BIOC), Orexigen (OREX)

So far Monday, June 18, NASDAQ is up 0.48% and the S&P is up 0.77%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Arrowhead Research More »